Wegovy is coming in tablet form.
*OASIS 4, 64-week study of adults with obesity using oral semaglutide alongside lifestyle changes.
Individual results vary.

Is this treatment right for you?
Based on the OASIS clinical trials, the oral semaglutide tablet has shown some promising results when used alongside diet and lifestyle changes.

Achieve an average weight reduction of 13.6-17% over 64 weeks when combined with a healthy lifestyle.

Taken as a convenient once-daily tablet, offering an alternative to weekly injections.

Powered by semaglutide, a GLP-1 medication that helps control appetite, supports feelings of fullness, and may reduce food cravings.
Results you can expect
Average weight loss across 3 treatments, from clinical studies where
patients increased to the highest dose.

Quick, effortless, and accomplished in less than 2 minutes!
Experience the simplicity of our service through 3 easy steps!
Our team combines decades of healthcare experience to provide safe, effective, and personalised treatments.

Aisana Pandya
Clinical Lead, Pharmacist, Independent Prescriber
Master of Pharmacy (MPharm)
Independent Prescribing Course (2019)
GPhC Number: 2085970

Justin Dicks
Superintendent Pharmacist
Bachelors in Nutrition & Dietetics
GPhC Number: 2038305

Lara Dunn-Ceylan
Dietician
Bachelor of Pharmacy (BPharm)
Our patient care team is excellent!